Torrance, CA, United States of America

Larry Robin Chan

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Varda Space Industries, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Larry Robin Chan: Innovator in Pharmaceutical Processes

Introduction

Larry Robin Chan is a notable inventor based in Torrance, California. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of solid-state forms of medications. His innovative approaches have the potential to enhance the efficiency of drug production.

Latest Patents

Larry Robin Chan holds a patent for "Processes for preparing solid state forms." This patent focuses on a polymorphic form of ritonavir, which is prepared using novel methods that require less time to produce the polymorphic form. The patent also covers pharmaceutical compositions that include the polymorphic form produced by these methods, along with corresponding methods of treatment.

Career Highlights

Chan is currently employed at Varda Space Industries, Inc., where he applies his expertise in pharmaceutical processes. His work is instrumental in advancing the company's goals in the space industry, particularly in the development of innovative solutions for drug delivery and production in space environments.

Collaborations

Some of his coworkers include Adrian Radocea and Jordan Michael Croom, who collaborate with him on various projects within the company. Their combined efforts contribute to the advancement of pharmaceutical technologies and processes.

Conclusion

Larry Robin Chan's contributions to the field of pharmaceuticals through his innovative patent and work at Varda Space Industries, Inc. highlight his role as a key inventor in the industry. His advancements in drug preparation processes are paving the way for more efficient pharmaceutical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…